| Texto completo | |
| Autor(es): |
Camargo, Cristina Pires
;
Guido, Maria Carolina
;
Tavares, Elaine Rufo
;
Carvalho, Priscila Oliveira
;
Gemperli, Rolf
;
Maranhao, Raul Cavalcante
Número total de Autores: 6
|
| Tipo de documento: | Artigo Científico |
| Fonte: | Journal of Drug Targeting; v. N/A, p. 9-pg., 2024-09-26. |
| Resumo | |
Skin flaps are employed to cover cutaneous denuded surfaces, but ensuing flap necrosis often occurs. Previously, rats with myocardial infarction treated with lipid-core nanoparticles (LDE) loaded with methotrexate (MTX) improved myocardial irrigation and reduced necrosis. Here, the aim was to investigate the efficacy of LDE-MTX to preserve the viability of cutaneous flaps and its implications for surgical wound healing. Twenty-eight male rats were divided into 4 groups: (1) LDE, injected intraperitoneally with LDE only; (2) MTX (1 mg/Kg commercial MTX): (3) LDE-MTX (1 mg/Kg MTX associated with LDE), and controls without treatment. LDE, MTX or LDE-MTX were repeated after 2 days. Then, flap surgery (9x3cm) was performed on the dorsal region. Injections were continued every other day until day 7 when animals were euthanized. LDE-MTX treatment improved the total viable area of the flaps with a fourfold increase in blood flow and reduced inflammatory cell number (p < 0.001), accompanied by decreased protein expression of pro-inflammatory factors. SOD-1 was higher in LDE-MTX-treated rats (p < 0.05). In conclusion, LDE-MTX treatment achieved total viability of cutaneous flaps, with increased irrigation and diminished local inflammation. LDE-MTX may offer efficient and cost-effective prevention of cutaneous flaps and treatment for wounds from surgical procedures to be tested in future clinical studies. (AU) | |
| Processo FAPESP: | 20/16215-0 - Nanopartículas lipídicas (LDE) como veículos de quimioterápicos: novo paradigma para a terapêutica médica |
| Beneficiário: | Raul Cavalcante Maranhao |
| Modalidade de apoio: | Auxílio à Pesquisa - Temático |